Insulin degludec reduces risk of severe hypoglycaemia
- PRATLEY RE, et al. Cardiovascular (CV) Safety and Severe Hypoglycemia Benefit of Insulin Degludec vs. Insulin Glargine U100 in Older Patients (≥65 Years) with Type 2 Diabetes (T2D) - Observations from DEVOTE 78th Annual Scientific Sessions of the American Diabetes Association : abstr. 108-OR, 22 Jun 2018. Available from: URL: https://plan.core-apps.com/tristar_ada18/abstract/807d2f9885450670bb994661e361a8c0.
© Springer Nature Switzerland AG 2018